Pregnancy outcomes after early fetal exposure to injectable first‐line treatments, dimethyl fumarate, or natalizumab in Danish women with multiple sclerosis

BACKGROUND AND PURPOSE: Data on pregnancy outcomes following fetal exposure to disease‐modifying drugs (DMDs) in women with multiple sclerosis (MS) are sparse although growing. METHODS: Data from the Danish Multiple Sclerosis Registry were linked with nationwide registries enabling an investigation...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersen, Johanna Balslev, Sellebjerg, Finn, Magyari, Melinda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Multiple Sclerosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092676/
https://www.ncbi.nlm.nih.gov/pubmed/36098960
http://dx.doi.org/10.1111/ene.15559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092676/
https://www.ncbi.nlm.nih.gov/pubmed/36098960
http://dx.doi.org/10.1111/ene.15559

Ejemplares similares